CURRENT AFFAIRS

Detailed explanation-1: -Smartphone linked artificial pancreas for type-1 diabetes.

Detailed explanation-2: -Professor Roman Hovorka at the University of Cambridge worked on the first artificial pancreas prototype. With our funding, he tested it in a world-first trial, which saw 24 people with with type 1 diabetes using the device in their own homes for a month.

Detailed explanation-3: -Lilly Diabetes Lilly is also working on its own connected insulin pen system, collaborating with Dexcom on the CGM side, and that pen-connected system is expected in 2022.

Detailed explanation-4: -There were three FDA approvals of artificial pancreas systems on the market: The Medtronic 670G, approved in 2016, the Tandem Control-IQ™, approved in 2019, and the Medtronic 770G, approved in 2020.

Detailed explanation-5: -An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.